Skip Navigation LinksHome > Advocacy > Correspondence

Correspondence

This section contains letters that have been sent or received by AABB on issues of concern to the transfusion medicine and cellular therapies communities.

2020

Joint Letter to FDA on Blood Supply Chain - 3/20/20
Joint Letter to HHS on Blood Supply Chain - 3/20/20
Joint Letter to CDC on Importance of Blood Donation - 3/13/20

2019

Joint Letters to Congress in Support of the “Patient Access to Cellular Transplant (PACT) Act - 11/5/19
Joint Letter to HHS Regarding BPAC and ACBTSA - 7/17/19
Joint Letter to ACBSCT Regarding Operational Challenges Experienced by Cord Blood Banks Resulting from Implementing FDA’s Zika Screening Guidance - 7/10/19
Joint Letter to Congress Supporting Pathogen Reduction Technology – 4/18/19
Joint Letter from Coalition of NHLBI Supporters to Congress Requesting Funding for NIH and NHLBI - 3/22/19
Joint Letter to Congress Regarding the Pandemic and All-Hazards Preparedness & Advancing Innovation Act (PAHPAI) – 3/22/19
Joint Letter to CMS Requesting the Establishment of a Miscellaneous Code for Blood Products – 1/4/19

2018

Joint Letter to Congress Supporting the Blood-Related Provisions in the Pandemic and All-Hazards Preparedness & Advancing Innovation Act – 12/7/18
Coalition Letter to Congress Regarding the Pandemic and All-Hazards Preparedness and Advancing Innovation (PAHPAI) Act – 12/5/18
Joint Letter to the ASPR Regarding the ASPR's Four Pillars to Achieving National Health Security - 10/23/18
Joint Letter to Congress Regarding Reauthorization of the Pandemic and All-Hazards Preparedness Act - 5/4/18
Joint letter to Congress in support of the Sickle Cell Disease Surveillance, Prevention, and Treatment Act ​of 2018 - 2/26/18
Joint Letter to FDA Regarding Hydroxyethyl Starch (HES)  - 2/6/18

2017

Letter to Congress in Support of Bill Requiring Medicare to Provide Separate Payments for the Acquisition of Hematopoietic Stem Cells - 11/29/2017
Letter to California Department of Public Health: Supports Modifying State Requirement that Registered Nurses be Physically Present During Blood Donation - 10/20/17
Joint Letter to FDA on Regulatory Reform - 10/19/17

2016

Letter to Congress Urging Rapid Enactment of Legislation for Emergency Zika Response - 6/15/16
Joint Letter to FDA Outlining Zika Concerns - 5/2/16

2012

FDA Response to AABB TTD Request for Review of Blood Relative vs. First Degree Relative in CJD Screening - 4/20/12 (PDF)